CORCEPT THERAPEUTICS INC（CORT）内部人交易：高管与董事近期交易
过去 18 个月，共有 14 位内部人为 CORCEPT THERAPEUTICS INC（CORT）报告了 435 笔 Form 4 交易（最近一笔 2026-10-05）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-05 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | 买入 | 413 | $3,416 |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | 买入 | 810 | $10,984 |
| 2026-10-05 | Vieira Roberto Wandenkolk | President, Oncology | 买入 | 8,333 | $180,243 |
| 2026-10-05 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | 卖出 | 413 | $47,717 |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | 卖出 | 810 | $93,473 |
| 2026-10-05 | Vieira Roberto Wandenkolk | President, Oncology | 卖出 | 1,100 | $125,973 |
| 2026-10-05 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | 买入 | 24,587 | $203,334 |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | 买入 | 3,357 | $45,521 |
| 2026-10-05 | Vieira Roberto Wandenkolk | President, Oncology | 卖出 | 2,086 | $241,412 |
| 2026-10-05 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | 卖出 | 15,843 | $1.8M |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | 买入 | 5,833 | $112,344 |
| 2026-10-05 | Vieira Roberto Wandenkolk | President, Oncology | 卖出 | 5,147 | $600,063 |
| 2026-10-05 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | 卖出 | 8,744 | $1.0M |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | 卖出 | 4,446 | $514,389 |
| 2026-10-05 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | 卖出 | 4,744 | $552,869 |
| 2026-09-28 | Robb Gary Charles | Chief Business Officer | 卖出 | 17,100 | $0 |
| 2026-09-28 | Robb Gary Charles | Chief Business Officer | 买入 | 5,000 | $0 |
| 2026-09-28 | Robb Gary Charles | Chief Business Officer | 买入 | 5,000 | $0 |
| 2026-09-18 | Robb Gary Charles | Chief Business Officer | 买入 | 17,493 | $144,667 |
| 2026-09-18 | Vieira Roberto Wandenkolk | President, Oncology | 卖出 | 296 | $29,843 |
| 2026-09-16 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | 买入 | 2,596 | $29,465 |
| 2026-09-16 | WILSON JAMES N | 董事 | 卖出 | 6,800 | $749,835 |
| 2026-09-16 | WILSON JAMES N | 董事 | 卖出 | 400 | $44,335 |
| 2026-09-16 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | 买入 | 7,404 | $100,398 |
| 2026-09-16 | WILSON JAMES N | 董事 | 卖出 | 2,800 | $312,771 |
来源：SEC Form 4 申报文件 · 截至 2026-10-05